Weave Communications (WEAV) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Weave Communications Inc (WEAV) Prix de l'Action, Cotation, Actualités et Historique

WEAVNYSE

Trade with Public

Trade with Public

$7.40

0.010.14%

Dern. MÀJ: Oct 16, 4:00 PM

$7.40

0.010.14%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

$7.39

Clôture

$7.40

Volume / Moy.

2.52M / 2.77M

Fourchette Journalière

$7.39 - $7.40

Plage 52 Sem.

4.24 - 7.70

Capitalisation Boursière

$595.33M

Ratio P/E

-

Rendement des Dividendes

-

Échange

NYSE

RSI

63

Intérêt à Découvert

7.52%

Jours pour Couvrir

3.11

Actualités Récentes de Weave Communications, Inc

Weave Is Going Private: Francisco Partners Offers 34% Premium in $650 Million Buyout

Weave Communications (WEAV) stock jumps 32% on a $650M buyout deal from Francisco Partners. Shareholders to receive $7.40 per share.

Lekha Gupta

Crude Oil Gains 1%; US Pending Home Sales Fall In July

US stocks fell in midday trading, with S&P 500 down 0.5% and Dow dropping 0.17%. Health care shares rose 1.6%, while tech stocks fell 2.1%.

Avi Kapoor

Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday

US stocks down, Nasdaq falls 300+ points. Duos Tech shares rise on better Q2 results. Many other big stocks gain, including Duolingo, Intuit, and Newsmax.

Avi Kapoor

Southern To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

Weave (WEAV) Improves DrChrono Integration for SMB Healthcare

Weave Communications (NYSE: WEAV) is expanding its footprint in the healthcare sector with its latest announcement of enhanced integration with a prominent electronic health record (EHR) provider, DrChrono, by EverHealth.

Zacks

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

16.85M

Flux de Trésorerie d'Investissement (TTM)

-3.52M

Flux de Trésorerie de Financement (TTM)

-10.37M

Flux de Trésorerie Libre (TTM)

11.02M

Dépenses en Capital (TTM)

-5.83M

Variation Nette de la Trésorerie (TTM)

2.97M

Tendances et prévisions des analystes

3

août

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

3.4

Conserver

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$568.25M

Ratio P/E (TTM)

-

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

2.25

Ratio P/B (TTM)

7.00

Rendement des Bénéfices % (TTM)

-3.65%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

-

Prix / EBITDA (TTM)

-

Prix / Flux de Trésorerie Libre (TTM)

52.60

Valeur Comptable / Action

$1.06

Dette Entreprise

Dette Totale

-

Dette à Long Terme

-

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-$7.24M

Trésorerie Totale

$47.63M

Dette sur Capitaux Propres

0.60

Émission de Dette (TTM)

-$7.24M

Remboursement de la Dette (TTM)

-$7.24M